Semax  SX10 10mg*10vials

Semax SX10 (10 vials, 10mg each) belongs to the Cognitive and Neuropeptide (CN peptide) category and is an upgraded version of the SX5 basic formula, offering higher efficiency and stronger efficacy. Semax is a high-quality synthetic neuromodulatory peptide derived from the ACTH fragment sequence, possessing unique central nervous system biological activity, zero immunogenicity, and excellent neurobiocompatibility. Semax overcomes the mild intervention threshold of low-dose Semax; the optimized 10mg high concentration significantly enhances neurotrophic activation, improves cognitive regulation efficacy, and deeply optimizes cerebral microcirculation. It targets and supports neuronal survival from multiple dimensions, reshapes neurotransmitter balance, regulates the central stress axis, and promotes adaptive repair of neural tissue. SX10 is specifically designed for modeling moderate to high-intensity neural injury, studying the mechanisms of higher cognitive function, intervening in chronic neural stress, and validating high-standard peptide-cognitive synergistic effects. It is a core upgraded preclinical research material for cutting-edge neurobiology, cognitive enhancement, and neural repair pharmacology research.

Product Functions and Research Value

Through in-depth and systematic laboratory research, Semax SX10 has demonstrated a comprehensively upgraded five-dimensional enhancement of neuromodulation efficacy, surpassing the steady-state intervention limits of the low-dose SX5 formulation. Its core upgraded research advantages encompass five key enhancement dimensions: efficient upregulation of neurotrophic factor expression, significantly improving neuronal survival under oxidative damage and hypoxic stress; enhanced regulation of multiple core neurotransmitter homeostasis, stabilizing cognitive phenotypes related to concentration and learning/memory; enhanced optimization of cerebral microcirculation and intracranial metabolic supply, alleviating chronic cerebral metabolic insufficiency; enhanced inhibition of central stress pathways, reversing stress-induced neuronal atrophy and cognitive decline; and promotion of adaptive remodeling of neural tissue, accelerating functional recovery after mild to moderate neurological injury. Chronic neurological stress, insufficient cerebral metabolism, and reduced endogenous neurotrophic factors are the core causes of cognitive decline and poor neurological function. Compared to the mild regulation of low doses, the 10mg double-concentration formulation of SX10 can more quickly and thoroughly reshape the neural microenvironment, effectively intervening in moderate cognitive decline and persistent neurological stress disorders that are insensitive to the basic formulation. It significantly enhances neuronal stress resistance, stabilizes cognitive-related neural circuit activity, and improves brain metabolic efficiency. The high-discrimination enhanced formulation exhibits significant experimental phenotypic amplification and stable, long-lasting neuromodulation effects, making it perfectly suited for modeling moderate-threshold neurological injury, exploring advanced cognitive mechanisms, intervening in chronic central stress, and optimizing complex peptide-mediated brain function. It provides high-precision, reproducible, and authoritative data for high-level preclinical cognitive and neuromodulation research.

Core Product Advantages

1. Doubled Concentration Enhanced Neurotrophic Activation: The 10mg high-load upgraded dose doubles the bioavailability of neuroactive fragments, significantly amplifying the upregulation efficiency of neurotrophic factors and breaking through the upper limit of low-dose neuroprotective efficacy.

2. Multi-Dimensional Cognitive Function Stabilization: A stronger neurotransmitter balance regulation capability effectively stabilizes neural activity related to learning, memory, and attention, providing richer research dimensions for exploring advanced cognitive mechanisms.

3. Deep Optimization of the Brain Metabolic Microenvironment: Further optimizes intracerebral blood microcirculation and energy metabolism supply, alleviating long-term insufficient brain perfusion and metabolic lag, and improving sub-healthy neurometabolic phenotypes. 4. Enhanced anti-stress neuroprotection: Stronger central stress axis regulation capacity, effectively improving stress-induced neuronal damage and cognitive fluctuations, and supporting in-depth research on stress-neuron-cognition related mechanisms.

5. High purity and vacuum-locked process: Utilizing upgraded multi-stage ultra-gradient deep purification and low-temperature vacuum freeze-drying technology, the active peptide structure is fully preserved, with extremely low impurity background, ensuring ultra-stable biological activity and highly reproducible experimental results.

6. Advanced standard aseptic packaging: 10-vial integrated dust-free aseptic packaging; each batch undergoes rigorous full-item HPLC high-purity testing and comes with a complete official Certificate of Account (COA). Long-lasting effect.